Kalyan R. Chitturi , Ryan Wallace , Abhishek Chaturvedi , Ilan Merdler , Nauman Khalid , Brian C. Case , Hayder D. Hashim , Itsik Ben-Dor , Toby Rogers , Ron Waksman
{"title":"与Impella CP相关的不良事件和失效模式:来自FDA MAUDE数据库的见解。","authors":"Kalyan R. Chitturi , Ryan Wallace , Abhishek Chaturvedi , Ilan Merdler , Nauman Khalid , Brian C. Case , Hayder D. Hashim , Itsik Ben-Dor , Toby Rogers , Ron Waksman","doi":"10.1016/j.carrev.2025.02.007","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":47657,"journal":{"name":"Cardiovascular Revascularization Medicine","volume":"76 ","pages":"Pages 110-112"},"PeriodicalIF":1.6000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Adverse events and failure modes related to Impella CP: Insights from the FDA MAUDE database\",\"authors\":\"Kalyan R. Chitturi , Ryan Wallace , Abhishek Chaturvedi , Ilan Merdler , Nauman Khalid , Brian C. Case , Hayder D. Hashim , Itsik Ben-Dor , Toby Rogers , Ron Waksman\",\"doi\":\"10.1016/j.carrev.2025.02.007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":47657,\"journal\":{\"name\":\"Cardiovascular Revascularization Medicine\",\"volume\":\"76 \",\"pages\":\"Pages 110-112\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiovascular Revascularization Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1553838925000569\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Revascularization Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1553838925000569","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
期刊介绍:
Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine. Cardiovascular Revascularization Medicine publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological interventions, restenosis management, and prevention, including experiments conducted in human subjects, in laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, etc.